OK, so maybe the Akesis clinical results last summer were positive, but check this out: Just weeks before the company filed for Chapter 7 after finding unacceptable renal toxicity associated with their vanadium program for diabetes, the study below was published (or at least the abstract was) discussing the promises of vanadium in treating diabetes.

The compound, called (bis(ethylmaltolato)oxovanadium (IV), BEOV) – which enhances the action of insulin – was invented and developed by University of British Columbia researchers Chris Orvig (pictured), professor of chemistry and pharmaceutical sciences, and John McNeill, Ph.D., professor and dean emeritus of pharmaceutical sciences.

The lesson here is to make sure you do your homework: make sure your compound or invention is clean before touting your stuff. And more importantly, get good management. Make sure that whoever is developing your life’s work has done it before, and has succeeded.

Nighty night!

Related Posts